Journals / Van Sağlık Bilimleri Dergisi / 2019 / Cilt: 12 - Sayı: 2

Determination of Median Values of First Trimester Screening Tests: A Tokat Scale Retrospective Study

Birinci Trimester Tarama Testlerinin Medyan Değerlerinin Belirlenmesi: Tokat Ölçekli Retrospektif Bir Çalışma

Pages
15–21
Publication Date
2019-12-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Determination of median values ​​specific to the region and even to the laboratory is now inevitable

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: The aim of this study was to determine the ability of maternal serum plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG) values ​​measured in the first trimester screening test to predict the complications that may develop in later gestational weeks, calculate the median values ​​of these parameters and compare them with those of software we use.
📊
Key Findings & Data:Materials and methods: The study included 16-46 years old women who applied to biochemistry laboratory of Tokat Gaziosmanpasa University School of Medicine with gestational ages of 10 weeks and 6 days to 13 weeks and 6 days.
💡
Conclusion & Impact:Determination of median values ​​specific to the region and even to the laboratory is now inevitable
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:free ß-hCG · PAPP-A · Double screening test

Abstract

Objectives: The aim of this study was to determine the ability of maternal serum plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG) values ​​measured in the first trimester screening test to predict the complications that may develop in later gestational weeks, calculate the median values ​​of these parameters and compare them with those of software we use. Materials and methods: The study included 16-46 years old women who applied to biochemistry laboratory of Tokat Gaziosmanpasa University School of Medicine with gestational ages of 10 weeks and 6 days to 13 weeks and 6 days. The results of 3166 pregnant women were evaluated retrospectively. Results: The mean age of the patients was 27.43 ± 5.46 and their weight was 65.66 ± 13.13 kilograms. Crown rump lengthes (CRL) were determined as 60.71 ± 8.56 mm. Free ß-hCG levels were 55.1 ± 132.07 ng / mL and PAPP-A values ​​were 3683.53 ± 2486 mIU / l. Nuchal translucency measurements (NT) were determined as 1.38 ± 0.37mm. PAPP-A and Free ß-hCG MoM values ​​were 1.23 ± 0.68 and 1.23 ± 0.88, respectively. New median values ​​of β-hCG were found to be significantly lower than those of the program (p <0.05), while PAPP-A values ​​were significantly higher (p <0.05). Conclusion: The accuracy and performance of first trimester screening tests should be improved. Determination of median values ​​specific to the region and even to the laboratory is now inevitable

Özet

Objectives: The aim of this study was to determine the ability of maternal serum plasma protein A (PAPP-A) and free beta-human chorionic gonadotropin (free ß-hCG) values ​​measured in the first trimester screening test to predict the complications that may develop in later gestational weeks, calculate the median values ​​of these parameters and compare them with those of software we use. Materials and methods: The study included 16-46 years old women who applied to biochemistry laboratory of Tokat Gaziosmanpasa University School of Medicine with gestational ages of 10 weeks and 6 days to 13 weeks and 6 days. The results of 3166 pregnant women were evaluated retrospectively. Results: The mean age of the patients was 27.43 ± 5.46 and their weight was 65.66 ± 13.13 kilograms. Crown rump lengthes (CRL) were determined as 60.71 ± 8.56 mm. Free ß-hCG levels were 55.1 ± 132.07 ng / mL and PAPP-A values ​​were 3683.53 ± 2486 mIU / l. Nuchal translucency measurements (NT) were determined as 1.38 ± 0.37mm. PAPP-A and Free ß-hCG MoM values ​​were 1.23 ± 0.68 and 1.23 ± 0.88, respectively. New median values ​​of β-hCG were found to be significantly lower than those of the program (p <0.05), while PAPP-A values ​​were significantly higher (p <0.05). Conclusion: The accuracy and performance of first trimester screening tests should be improved. Determination of median values ​​specific to the region and even to the laboratory is now inevitable

🔖

Cite This Article

Katar, M. (2019). Determination of Median Values of First Trimester Screening Tests: A Tokat Scale Retrospective Study. Van Sağlık Bilimleri Dergisi, Cilt: 12 - Sayı: 2, 15–21. https://ajindex.com/articles/821525

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Referans1. Alp, H. H., Z. Huyut, E. Çokluk, M. R. Şekeroğlu and A. Tıbbi Biyokimya "İkili ve Üçlü Prenatal Tarama Testi Medyan Değerleri: Van Ölçekli Retrospektif Bir Çalışma." Turkish Journal of Biochemistry/Turk Biyokimya Dergisi 16(1). Referans2. Ananth, C. V., R. J. Wapner, S. Ananth, M. E. D’Alton and A. M. Vintzileos (2017). "First-trimester and second-trimester maternal serum biomarkers as predictors of placental abruption." Obstetrics and gynecology 129(3): 465. Referans3. Assessment, P. R. (2000). "Down syndrome: prenatal risk assessment and diagnosis." Am Fam Physician 62(4): 825-832. Referans4. Atak, P. G., A. Arpacı and G. Seydal (2014). "Adıyaman iline ait ikili ve üçlü prenatal tarama testlerinin medyan değerlerinin belirlenmesi." Turkish Journal of Biochemistry/Turk Biyokimya Dergisi 39(2). Referans5. Brizot, M. L., R. J. Snijders, N. A. Bersinger, P. Kuhn and K. H. Nicolaides (1994). "Maternal serum pregnancy-associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy." Obstetrics and gynecology 84(6): 918-922. Referans6. Creasy, R. K., R. Resnik and J. D. Iams (2004). Maternal-fetal medicine: principles and practice, Gulf Professional Publishing.Cuckle, H. (2001). "Integrating antenatal Down's syndrome screening." Current Opinion in Obstetrics and Gynecology 13(2): 175-181. Referans7. Goetzl, L. (2002). "ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin. Clinical Management Guideline for Obstetrician-Gynecologists Number 36, July 2002.
  2. Obstetric analgesia and anesthesia." Obstet Gynecol. 100: 177-191. Referans8. Holding, S. (1991). "Biochemical screening for Down's syndrome." BMJ: British Medical Journal 302(6787): 1275. Referans9. James, D., P. Steer, C. Weiner and B. Gonik (2008). "Yüksek Riskli Gebelikler Yönetim Seçenekleri." Erken prenatal bakım (Derleyen: Güner H), Güneş Tıp Kitabevleri, İstanbul 65. Referans10. Kagan, K. O., J. Sonek, P. Wagner and M. Hoopmann (2017). "Principles of first trimester screening in the age of non-invasive prenatal diagnosis: screening for chromosomal abnormalities." Archives of gynecology and obstetrics 296(4): 645-651. Referans11. Kappel, B., J. Nielsen, K. B. Hansen, M. Mikkelsen and A. J. Therkelsen (1987). "Spontaneous abortion following mid‐trimester amniocentesis. Clinical significance of placental perforation and blood‐stained amniotic fluid." BJOG: An International Journal of Obstetrics & Gynaecology 94(1): 50